The project concerns financing of research and development (R&D) activities relating to innovative new products, among others in the areas of skin care and healthy nutrition.
Objectives
The project aims to encourage research and technological development, as defined in Article 163 of the EC Treaty, and with the "Common Interest" criterion retained for the Treaty's Article 267 point (c), i.e. the Bank's financing activities under Knowledge Economy (i2i), (i) research and development and (ii) innovation.
Comments
Sector(s)
Industry
Proposed EIB finance (Approximate amount)
EUR 125 million
Total cost (Approximate amount)
EUR 250 million
Environmental aspects
R&D activities included in the project will not materially change current practice and will be carried out within existing facilities and laboratories, pilot plants, clinical centres, etc. An Environmental Impact Assessment (EIA) by a competent authority according to the Directive 2011/92/EU should not be required. This, along with any other environmental details, will be verified during the appraisal.
Procurement
The promoter is a private company not operating in the utilities sector, and is thus not covered by EU Directives on procurement.
Status
Signed
-
08/03/2013.
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. Therefore data provided on this page is indicative and cannot be considered to represent official EIB Policy (see also the Explanatory notes).
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities. Enquiries and comments regarding the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, EIB can also be contacted through its external offices.
Queries regarding details of a specific project, in particular when EIB loan is under appraisal, should be preferably addressed directly to project promoters.
Any complaint regarding alleged maladministration can be lodged to EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero-tolerance against fraud and corruption
The EIB has a zero-tolerance policy on fraud or corruption. To report allegations of fraud or corruption in EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential, and are handled in line with EIB investigation procedures and the Anti-Fraud Policy.
The EIB is committed to achieving the highest possible level of transparency. The EIB Transparency Policy sets out how EIB discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations.
